Maravai LifeSciences Holdings, Inc.
MRVI
$3.08
-$0.21-6.38%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 216.89M | 243.57M | 269.91M | 285.05M | 323.77M |
| Total Receivables | 25.50M | 22.54M | 27.88M | 28.49M | 38.52M |
| Inventory | 40.50M | 45.33M | 46.67M | 49.77M | 50.08M |
| Prepaid Expenses | 13.37M | 14.43M | 15.31M | 12.96M | 16.77M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 296.25M | 325.87M | 359.76M | 376.28M | 429.15M |
|
|
|||||
| Total Current Assets | 296.25M | 325.87M | 359.76M | 376.28M | 429.15M |
| Net Property, Plant & Equipment | 190.74M | 158.62M | 162.73M | 166.43M | 217.03M |
| Long-term Investments | 129.43M | 129.43M | 129.43M | 159.88M | 159.88M |
| Goodwill | 129.43M | 129.43M | 129.43M | 159.88M | 159.88M |
| Total Other Intangibles | 151.54M | 185.88M | 193.07M | 199.58M | 194.96M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.62M | 49.40M | 51.98M | 57.58M | 7.24M |
| Total Assets | 770.58M | 849.19M | 896.97M | 959.75M | 1.01B |
|
|
|||||
| Total Accounts Payable | 2.91M | 8.00M | 11.53M | 9.53M | 11.96M |
| Total Accrued Expenses | 22.60M | 31.12M | 23.98M | 26.08M | 28.02M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 14.20M | 14.50M | 14.24M | 16.95M | 13.71M |
| Total Finance Division Other Current Liabilities | 5.21M | 7.96M | 19.94M | 10.60M | 3.29M |
| Total Other Current Liabilities | 5.21M | 7.96M | 19.94M | 10.60M | 3.29M |
| Total Current Liabilities | 44.92M | 61.57M | 69.68M | 63.16M | 56.97M |
|
|
|||||
| Total Current Liabilities | 44.92M | 61.57M | 69.68M | 63.16M | 56.97M |
| Long-Term Debt | 286.33M | 287.38M | 288.44M | 289.50M | 290.49M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 64.18M | 66.06M | 68.40M | 74.54M | 72.49M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2.44M | 2.32M | 2.46M | 2.28M | 11.09M |
| Total Liabilities | 397.87M | 417.33M | 428.98M | 429.48M | 431.04M |
|
|
|||||
| Common Stock & APIC | 201.74M | 199.07M | 193.93M | 189.34M | 184.40M |
| Retained Earnings | 10.12M | 45.80M | 71.36M | 110.95M | 140.89M |
| Treasury Stock & Other | 524.00K | 579.00K | 574.00K | 324.00K | -- |
| Total Common Equity | 212.38M | 245.44M | 265.86M | 300.61M | 325.29M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 212.38M | 245.44M | 265.86M | 300.61M | 325.29M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 160.33M | 186.42M | 202.12M | 229.66M | 251.92M |
| Total Equity | 372.71M | 431.86M | 467.98M | 530.27M | 577.21M |
|
|
|||||